Sono-Tek Reports Strong First-Half Financial Performance

MILTON, N.Y., Oct. 14, 2026 /CourierPR/ -- Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of precision ultrasonic coating systems, reported significant financial results for the second quarter and first half of fiscal year 2027, ending August 31, 2026. The company's revenue increased by 6% to $10.9 million, while gross margin expanded to 55%, marking a notable improvement from the 51% recorded in the prior-year period. Operating income increased by 41% to $1.28 million, reflecting a 41% rise in gross profit, and net income grew by 22% to $1.11 million, up from $909,000 in the previous year.

In the medical market, Sono-Tek saw an extraordinary increase of 289% in sales, reaching $7.05 million. This significant growth was driven by the shipment of balloon coating systems and specialty stent-coating systems. The company's overall revenue for the first half of fiscal year 2027 was $10.89 million, a 6% increase from the $10.30 million reported in the first half of fiscal year 2026. Gross profit for the period also saw a notable rise, increasing by 14% to $5.98 million, and the gross margin expanded to 55%, up from 51% in the prior-year period.

Sono-Tek Corporation, which operates under the Nasdaq ticker symbol SOTK, has maintained a strong financial position, with cash, cash equivalents, and marketable securities totaling $17.7 million as of August 31, 2026. This represents a 19% increase from the $14.8 million reported at the end of the first quarter of fiscal year 2027. The company's backlog also saw a significant increase, rising to $9.51 million at the end of the first half of fiscal year 2027, up from $7.73 million at the end of the first quarter of fiscal year 2027. Subsequent to the quarter end, the company received three orders totaling approximately $7.19 million, expected to ship during fiscal year 2028, significantly increasing revenue visibility for fiscal year 2028.

Sono-Tek Corporation reiterated its expectation of flat to modest revenue growth for fiscal year 2027, attributing this outlook to the timing of several large orders, growing demand in the medical device market, and the introduction of higher-value production systems. The company's President and Chief Executive Officer, Steve Harshbarger, highlighted the company's strong performance, emphasizing the growth in the medical market, which increased by 289% in the first half of fiscal year 2027, driven by the strong demand for balloon coating and specialty stent-coating systems. Harshbarger also noted the company's focus on expanding its installed base of production systems, supporting customers as they scale, and investing in the engineering, application development, and commercial capabilities that will drive the next phase of growth.

The company's financial performance is supported by a comprehensive suite of thin film coating solutions and application consulting services, which are expected to generate unparalleled results for its clients and help some of the world's most promising companies achieve technological breakthroughs and bring them to market. Sono-Tek Corporation's solutions are environmentally friendly, efficient, and highly reliable, enabling dramatic reductions in overspray, savings in raw materials, water, and energy usage.